Help them to breathe easy

We improve the prevention, diagnosis and treatment of pneumonia to save the lives of thousands of children all over the world.


    We work in alliance with UNICEF to combat pneumonia, which kills 940,000 children under five every year and has become the world's major cause of infant mortality.

    Less developed countries suffer from considerable limitations in their healthcare, diagnosis and treatment  of this illness and, in spite of the positive trend over the last few years, care services are still insufficient and don't manage to reach the most vulnerable children.
    Reducing children's deaths from pneumonia requires a comprehensive but focused approach via international strategic alliances to work on prevention, diagnosis and treatment.

    For this reason the "la Caixa" Foundation has set up an alliance with UNICEF that focuses on improving diagnosis and treatment and further strengthens the commitment that began with the GAVI alliance for vaccination  (prevention).

    The ARIDA programme (Acute Respiratory Infection Diagnosis Aid) aims to develop and implement technological solutions that improve the detection and treatment of pneumonia, providing community health centres in the most vulnerable areas with new devices that diagnose pneumonia more accurately, easily and reliably.


    This programme is aimed at saving the lives of the hundreds of thousands of children who die from pneumonia every year.


    To tackle this urgent need and further the development of new diagnostic devices for pneumonia, the "la Caixa" Foundation and UNICEF promote a strategic global alliance to save the lives of hundreds of thousands of children via innovative, sustainable solutions. 

    The project will be implemented in 2 phases:

    • An initial pilot phase in which new automatic diagnostic devices (clinically approved and with their respective health authority permits) will be distributed and tested in different countries , starting with Ethiopia, subsequently analysing the results and evaluating how they have improved diagnosis.

    • A second phase, based on the results from the first phase, involving a larger scale roll-out in which the protocols, guidelines, marketing strategies, etc. will be developed.

    It's estimated that around 120,000 children will benefit directly from the first stage but, in addition to improving the diagnosis of pneumonia in these children and therefore ensuring they get the right treatment, this phase will also provide UNICEF with valuable and strategic knowledge to promote improvements at a global level regarding how to diagnose pneumonia within rural areas in developing countries.

    Through this global strategic alliance between UNICEF and "la Caixa" we hope to reduce infant mortality caused by pneumonia via three key activities:

    • Improve the diagnosis of pneumonia using innovative solutions that automatically measure children's breathing.

    • Improve the skills of community healthcare workers in using new technological aids that help them in their diagnosis and enhance their decisions.

    • Increase the availability at healthcare centres of Amoxicillin in adequate doses for children under five.

  • This alliance will reinforce the efforts made by governments against pneumonia.

  • More than 120,000 children have benefitted from the project's initial phase.

  • Innovative technological devices to detect pneumonia.